Log In
Print this Print this


  Manage Alerts
Collapse Summary General Information
Company MarcoPolo Pharmaceuticals S.A.
DescriptionMT3/quinone oxidoreductase 2 (QR2) receptor modulator
Molecular Target MT3/quinone oxidoreductase 2 (QR2) receptor
Mechanism of Action 
Therapeutic Modality 
Latest Stage of DevelopmentPhase II/III
Standard IndicationEpilepsy
Indication DetailsTreat epilepsy in patients with refractory partial seizures
Regulatory Designation

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today